Azimilide Post-Infarct Survival Evaluation - ALIVE

Description:

In this randomized, placebo-controlled, double-blind study, azimilide was investigated for its effects on mortality in patients with depressed left ventricular function after recent myocardial infarction (MI) and in a subpopulation of patients with low heart rate variability (HRV).